Multiple Mitochondrial Dysfunctions Syndrome: Clinical Trials

1 trial for Multiple Mitochondrial Dysfunctions Syndrome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable1Completed 1

Follow Multiple Mitochondrial Dysfunctions Syndrome: new trials by email Literature Review of Multiple Mitochondrial Dysfunctions Syndrome trials Research Report on Multiple Mitochondrial Dysfunctions Syndrome

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Dapagliflozin on Mitochondrial Dysfunction and Impaired Insulin Signaling/Action
Dapagliflozin, Placebo - Insulin Sensitivity, Multiple Mitochondrial Dysfunctions Syndrome
Not applicableCompletedThe University of Texas Health Science Center at San Antonio182011-03-012025-07-03

Narrower conditions

Glycosuria (1)  ·  Insulin Resistance (1)

Broader conditions

Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Glucose Metabolism Disorders (1)  ·  Hyperinsulinism (1)  ·  Male Urogenital Diseases (1)  ·  Metabolic Diseases (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Urination Disorders (1)  ·  Urogenital Diseases (1)  ·  Urologic Diseases (1)

Interventions

dapagliflozin (1)

Sponsors

The University of Texas Health Science Center at San Antonio (1)

Countries

United States (1)

Top investigators

Devjit Tripathy, MD (1)  ·  Ralph DeFronzo, MD (1)

Results publications

PMID 27561923

NIH funding

R01DK024092 (1)